D.E. Shaw & Co’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.27M Sell
76,781
-40,105
-34% -$1.62M ﹤0.01% 2517
2025
Q4
$4.38M Buy
116,886
+64,090
+121% +$2.15M ﹤0.01% 2416
2025
Q3
$1.56M Sell
52,796
-444,384
-89% -$10.3M ﹤0.01% 3159
2025
Q2
$11.7M Buy
497,180
+314,277
+172% +$6.56M 0.01% 1380
2025
Q1
$3.31M Buy
182,903
+45,701
+33% +$897K ﹤0.01% 2212
2024
Q4
$2.34M Buy
+137,202
New +$2.37M ﹤0.01% 2607

Other funds holding BTSG

D.E. Shaw & Co's BTSG Position: Q1 2026 in Review

D.E. Shaw & Co reduced its BrightSpring Health Services (BTSG) stake by 34% in Q1 2026, selling an estimated $1.62M and leaving 76,781 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

D.E. Shaw & Co first reported a position in BTSG in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.7M in Q2 2025. 335 funds tracked by Wall St. Rank hold BTSG as of Q1 2026.

  • D.E. Shaw & Co held 76,781 shares of BrightSpring Health Services worth $3.27M as of Q1 2026.
  • D.E. Shaw & Co sold 40,105 BrightSpring Health Services shares in Q1 2026, an estimated $1.62M.
  • BrightSpring Health Services made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2517 holding.
  • D.E. Shaw & Co first reported a position in BrightSpring Health Services in Q4 2024 and has held it in 6 quarters since.
  • D.E. Shaw & Co's BrightSpring Health Services position peaked at $11.7M in Q2 2025.
  • 335 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.